{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:23:15Z","timestamp":1755220995102,"version":"3.43.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1023\/a:1011904718960","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T06:29:09Z","timestamp":1040624949000},"page":"203-209","source":"Crossref","is-referenced-by-count":1,"title":["Short-Term Comparative Outcomes Associated with the Use of GP IIb\/IIIa Antagonists in Patients Undergoing Coronary Intervention"],"prefix":"10.1007","volume":"11","author":[{"given":"Carey","family":"Kimmelstiel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Phang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asif","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Rand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Miele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Rhofiry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra A.","family":"MacIsaac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Gouveia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Denier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"357037_CR1","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199404073301402","volume":"330","author":"EPIC Investigators.","year":"1994","unstructured":"EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956\u2013961.","journal-title":"N Engl J Med"},{"key":"357037_CR2","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199706123362401","volume":"336","author":"EPILOG Investigators.","year":"1997","unstructured":"EPILOG Investigators. Platelet glycoprotein IIb\/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689\u20131696.","journal-title":"N Engl J Med"},{"key":"357037_CR3","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(96)10172-0","volume":"349","author":"Impact Investigators.","year":"1997","unstructured":"Impact Investigators. Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Lancet 1997;349:1422\u20131428.","journal-title":"Lancet"},{"key":"357037_CR4","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/01.CIR.96.5.1445","volume":"96","author":"RESTORE Investigators.","year":"1997","unstructured":"RESTORE Investigators. Effects of platelet glycoprotein IIb\/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation 1997;96:1445\u20131453.","journal-title":"Circulation"},{"key":"357037_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1023\/A:1018775015882","volume":"9","author":"FH Jafary","year":"2000","unstructured":"Jafary FH, Kimmelstiel CD. Antiplatelet therapy in interventional cardiology: II. Glycoprotein IIb\/IIIa inhibitors. J Thromb Thrombolysis 2000;9:163\u2013174.","journal-title":"J Thromb Thrombolysis"},{"key":"357037_CR6","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","volume":"338","author":"PRISM-PLUS Study Investigators.","year":"1998","unstructured":"PRISM-PLUS Study Investigators. Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998;338:1488\u20131497.","journal-title":"N Engl J Med"},{"key":"357037_CR7","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1001\/jama.281.15.1407","volume":"281","author":"DA Vorchheimer","year":"1999","unstructured":"Vorchheimer DA, Badimon JJ, Fuster V. Platelet glycoprotein IIb\/IIIa receptor antagonists in cardiovascular disease. JAMA 1999;281:1407\u20131414.","journal-title":"JAMA"},{"key":"357037_CR8","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S0735-1097(00)00554-4","volume":"35","author":"AM Lincoff","year":"2000","unstructured":"Lincoff AM, Califf RM, Topol EJ. Platelet glycoprotein IIb\/IIIa receptor blockade in coronary artery disease. J Am Coll Cardiol 2000;35:1103\u20131115.","journal-title":"J Am Coll Cardiol"},{"key":"357037_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0140-6736(98)11086-3","volume":"353","author":"EJ Topol","year":"1999","unstructured":"Topol EJ, Byzova TV, Plow EF. Platelet GPIIb-IIIa blockers. Lancet 1999;353:227\u2013231.","journal-title":"Lancet"},{"key":"357037_CR10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)06113-3","volume":"352","author":"EPISTENT Investigators.","year":"1998","unstructured":"EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb\/IIIa blockade. Lancet 1998;352:87\u201392.","journal-title":"Lancet"},{"key":"357037_CR11","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1161\/01.CIR.98.23.2629","volume":"98","author":"M Madan","year":"1998","unstructured":"Madan M, Berkowitz SD, Tcheng JE. Glycoprotein IIb\/ IIIa integrin blockade. Circulation 1998;98:2629\u20132635.","journal-title":"Circulation"},{"key":"357037_CR12","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1161\/01.CIR.98.17.1802","volume":"98","author":"EJ Topol","year":"1998","unstructured":"Topol EJ, Serruys PW. Frontiers in interventional cardiology. Circulation 1998;98:1802\u20131820.","journal-title":"Circulation"},{"key":"357037_CR13","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1161\/01.CIR.98.24.2695","volume":"98","author":"F-J Neumann","year":"1998","unstructured":"Neumann F-J, Blasini R, Schmitt C, et al. Effect of glycoprotein IIb\/IIIa receptor blockade on recovery of coronary flow and left ventricular function after placement of coronary artery stents in acute myocardial infarction. Circulation 1998;98:2695\u20132701.","journal-title":"Circulation"},{"key":"357037_CR14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","volume":"339","author":"PURSUIT Trial Investigators.","year":"1998","unstructured":"PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998;339: 436\u2013443.","journal-title":"N Engl J Med"},{"key":"357037_CR15","doi-asserted-by":"crossref","unstructured":"Topol E. Do tirofiban and reopro give similar efficacy outcomes trial (TARGET). Oral presentation Annual Scientific Sessions, American Heart Association, New Orleans, Louisiana 2000.","DOI":"10.1161\/01.CIR.102.21.2672-l"},{"key":"357037_CR16","unstructured":"Tcheng JE, Madan M, Cohen EA, et al. Enhanced suppression of the platelet receptor using integrilin (eptifibatide) therapy, American College of Cardiology Annual Scientific Session, Anaheim, CA, March, 2000."},{"key":"357037_CR17","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/S0002-8703(99)70445-X","volume":"137","author":"DB Mark","year":"1999","unstructured":"Mark DB, Simons TA. Use of abciximab: Comparative economic data. Am Heart J 1999;137:S123\u2013S125.","journal-title":"Am Heart J"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1011904718960.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1011904718960\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1011904718960.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T07:11:24Z","timestamp":1754637084000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1011904718960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["357037"],"URL":"https:\/\/doi.org\/10.1023\/a:1011904718960","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"type":"print","value":"0929-5305"},{"type":"electronic","value":"1573-742X"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}